
An important aspect of our work is investigating how targeted nutrition and exercise interventions can mitigate the effects of chronic inflammatory diseases. Current research is exploring the anti-inflammatory potential of omega-3 fatty acids and their role in promoting the production of specialized pro-resolving mediators (SPMs) to reduce inflammation and improve metabolic health in individuals with obesity. Overall, our group aims to develop evidence-based approaches that enhance health outcomes and improve quality of life for individuals managing chronic inflammation and metabolic disorders.
Our lab utilizes advanced clinical methodologies and is equipped to perform overnight metabolic assessments, providing invaluable insights into disease prevention and metabolic adaptation. Current capabilities include: